Tasman Medical Journal

ISSN: 2652-1881

Arrow-left

LATEST ARTICLE

A new open-access general medical journal for Australia and New Zealand

A new open-access general medical journal for Australia and New Zealand

LATEST ARTICLE

Recent Articles

Trends in acute myeloid leukaemia in Western Australia over time: Improved outcomes with contemporary management

IntroductionReal-world outcomes of acute myeloid leukaemia (AML) are poor compared to the results of clinical trials.  This partially reflects population differences due to patient selection criteria in trials (excluding older and unfit patients who are unsuitable for aggressive treatment), and lack of improvement in the efficacy of intensive chemotherapy over time.  However, there have been successful developments in AML management including improved non-intensive therapies, laboratory diagnostics to stratify patient risk, donor selection for allogeneic stem cell transplantation (allo-SCT) and supportive

Read Article »

An audit of clinical service delivery and outcomes in diffuse idiopathic skeletal hyperostosis – preliminary evidence for efficacy of tumour necrosis factor inhibition therapy

IntroductionDiffuse idiopathic skeletal hyperostosis (DISH), also known as Forestier’s disease or ankylosing hyperostosis, is a common skeletal disorder, which is reported to range in frequency from 3.8% of males and 2.6% of females in a Finnish population-based study to 22.4% of males and 13.4% of females in an Israeli hospital-based study.1, 2 The disorder was first described by Forestier, Jacqueline and Rotes-Querol in 1950.3  The skeletal phenotype suggests it is an historically ancient disorder, but the pathophysiology is still poorly

Read Article »

Life AfTER covid-19 (LATER-19): a protocol for a prospective, longitudinal, cohort study of symptoms, physical function and psychological outcomes in the context of a pandemic

IntroductionPatients infected with SARS-CoV-2 (COVID-19 disease) present with respiratory tract infection and symptoms such as fever, cough, fatigue, sputum production and/or breathlessness.1 The spectrum of COVID-19 varies from asymptomatic infection through mild upper respiratory tract illness, to severe and potentially fatal viral pneumonia with respiratory failure. The Chinese Centre for Disease Control and Prevention reported that 70,420 of the 80,928 confirmed cases in China are “cured and discharged from hospital,” while 3,245 have died.2  However, in the early stage of

Read Article »

Face-Touching behaviour modification in ICU staff during the COVID-19 pandemic

IntroductionThere has been a rapid global pandemic spread of SARS-CoV-2 virus (COVID-19). Viral particles which come into contact with mucous membranes lead to infection of respiratory tract epithelium and induce an inflammatory response that varies in degree but may be fatal.1 An important source of infectious particles is believed to be fomites that may be touched by potential patients or their doctors and transferred to mucous membranes by touch.  Previous coronaviruses have been shown to be able to live on

Read Article »

Current Issue

Journal Subscription

Subscribe to Tasman Medical Journal

Receive the Latest Tasman Medical Journal articles as they are published. 

Subscription is free

For Authors

Doctor Typing

Find out how to publish your work in the Tasman Medical Journal.